NasdaqCM - Delayed Quote USD

Viracta Therapeutics, Inc. (VIRX)

0.0189
-0.0001
(-0.53%)
At close: May 13 at 1:16:34 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
47,212
50,693
50,589
25,798
18,815
Operating Income
-47,212
-50,693
-50,589
-25,798
-18,815
Net Non Operating Interest Income Expense
-1,069
-359
594
-453
-168
Other Income Expense
4,992
-6
798
-88,511
-34
Pretax Income
-43,289
-51,058
-49,197
-114,762
-19,017
Net Income Common Stockholders
-43,289
-51,058
-49,197
-114,762
-19,017
Diluted NI Available to Com Stockholders
-43,289
-51,058
-49,197
-114,762
-19,017
Basic EPS
-1.10
-1.32
-1.30
-3.60
-0.51
Diluted EPS
-1.10
-1.32
-1.30
-3.60
-0.51
Basic Average Shares
39,274.2100
38,624.4620
37,790.9810
31,870.0670
36,994.6230
Diluted Average Shares
39,274.2100
38,624.4620
37,790.9810
31,870.0670
36,994.6230
Total Operating Income as Reported
-47,212
-50,693
-50,589
-114,276
-18,815
Total Expenses
47,212
50,693
50,589
25,798
18,815
Net Income from Continuing & Discontinued Operation
-43,289
-51,058
-49,197
-114,762
-19,017
Normalized Income
-43,289
-51,058
-49,197
-26,541
-19,017
Interest Income
2,113
3,345
1,171
38
48
Interest Expense
3,182
3,704
577
491
216
Net Interest Income
-1,069
-359
594
-453
-168
EBIT
-40,107
-47,354
-48,620
-114,271
-18,801
EBITDA
-39,668
-46,862
-48,410
-114,093
-18,769
Reconciled Depreciation
439
492
210
178
32
Net Income from Continuing Operation Net Minority Interest
-43,289
-51,058
-49,197
-114,762
-19,017
Total Unusual Items Excluding Goodwill
0
--
0
-88,221
0
Total Unusual Items
0
--
0
-88,221
0
Normalized EBITDA
-39,668
-46,862
-48,410
-25,872
-18,769
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 9/27/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

I9DN.MU Arbutus Biopharma Corp
2.8260
-4.33%
 
I9DN.F Arbutus Biopharma Corporation
2.9360
+2.80%
 
RAONF Race Oncology Limited
1.2200
0.00%
 
SRBCF Sirona Biochem Corp.
0.0043
0.00%
 
NMTRQ 9 Meters Biopharma, Inc.
0.0001
0.00%
 
SABSW SAB Biotherapeutics, Inc.
0.0222
-21.83%
 
VYNE VYNE Therapeutics Inc.
1.3100
+4.80%
 
ACRV Acrivon Therapeutics, Inc.
1.1300
-5.83%
 
APTOF Aptose Biosciences Inc.
1.7800
+7.88%
 
CDTTW Conduit Pharmaceuticals Inc.
0.0086
+8.86%